Teneligliptin Hydrobromide Hydrate 20mg Tablets

Pack: 10 tablets/strip

DOSAGE: 1 to 2 Tablets per day

SPRINGER ADVANCES IN THERAPY

The safety profile of teneligliptin in this post-marketing surveillance of patients with T2DM in long-term, real-world clinical practice did not differ markedly from the established safety profiles of teneligliptin or other DPP4 inhibitors. The surveillance also confirmed that the efficacy of teneligliptin is maintained for up to 3 years in real-world settings supporting its long-term use. The safety and efficacy of teneligliptin were also maintained in patients with renal impairment and in patients on dialysis.

Indication:

• Type Il diabetes
• Diabetic Patients with Cardiovascular disease
• Elderly diabetic patient
• Metformin Intolerable patient
• insulin secretion